TABLE 2.
The common cardiovascular complication reported according to the case series drug analysis print published by United Kingdom (UK) government for AstraZeneca vaccine
| Specific adverse event | Total number of events | Fatal events |
|---|---|---|
| Myocarditis | 105 | 1 |
| Pericarditis | 162 | 0 |
| Thrombosis | 1712 | 33 |
| Pulmonary embolism | 1582 | 100 |
| DVT | 1173 | 9 |
| CVST | 207 | 22 |
| Mesenteric vein thrombosis | 20 | 0 |
| Pelvic venous thrombosis | 22 | 1 |
| Splenic vein thrombosis | 10 | 0 |
| Hepatic vein thrombosis | 16 | 0 |
| Thrombocytopenia | 868 | 6 |
| Hypertension | 941 | 0 |
| Hypertensive crisis | 14 | 0 |
| Hypertension urgency | 4 | 0 |
| Malignant hypertension | 4 | 0 |
| Myocardial infarction | 386 | 51 |
| Acute myocardial infarction | 79 | 13 |
| Angina pectoris | 219 | 0 |
| Stress cardiomyopathy | 5 | 0 |
| Palpitation | 5157 | 1 |
| Arrhythmia | 134 | 3 |
| Tachycardia | 1242 | 0 |
| Atrial fibrillation | 311 | 0 |
| Extrasystole | 142 | 0 |
| Sinus tachycardia | 69 | 1 |
| Supraventricular tachycardia | 41 | 0 |
| Bradycardia | 78 | 0 |
| Cardiac arrest | 167 | 35 |
| Death | 301 | 301 |
CVST, cerebral veinous sinus thrombosis; DVT, deep veinous thrombosis.